ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EPRX Eupraxia Pharmaceuticals Inc

3.72
0.03 (0.81%)
May 02 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Eupraxia Pharmaceuticals Inc EPRX Toronto Common Stock
  Price Change Change Percent Stock Price Last Traded
0.03 0.81% 3.72 15:59:58
Open Price Low Price High Price Close Price Prev Close
3.70 3.69 3.80 3.72 3.69
more quote information »

Recent News

Date Time Source Heading
5/02/202410:07IHNWFeaturedNanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon
5/02/202407:00PRNUSEupraxia Pharmaceuticals Announces Gastrointestinal Clinical..
4/11/202407:00PRNUSEupraxia Pharmaceuticals Announces Upcoming Presentations at..
4/08/202407:00PRNCAEupraxia Pharmaceuticals To Present at Bloom Burton & Co...
4/05/202407:00PRNUSEupraxia Pharmaceuticals Begins Trading on Nasdaq Today
4/03/202417:00PRNCAEupraxia Pharmaceuticals to Begin Trading on Nasdaq on April..
4/01/202417:01PRNCAEupraxia Pharmaceuticals Reports Fourth Quarter and 2023..
3/15/202408:26GLOBEEupraxia Pharmaceuticals Announces Closing of Overnight..
3/12/202409:41PRNCAL'Organisme canadien de réglementation des investissements..
3/12/202409:39PRNCACanadian Investment Regulatory Organization Trade Resumption..
3/12/202409:31GLOBEEupraxia Pharmaceuticals Announces Pricing of Overnight..
3/11/202416:08GLOBEEupraxia Pharmaceuticals Announces Overnight Marketed..
3/11/202416:06PRNCASuspension de la négociation par l'Organisme canadien de..
3/11/202416:04PRNCACanadian Investment Regulatory Organization Trading Halt -..
2/05/202417:00PRNCAEupraxia Pharmaceuticals Announces Updated Positive Clinical..
2/01/202407:00PRNCAEupraxia Pharmaceuticals Initiates Phase 3 Development..
1/30/202407:00PRNCAEupraxia Pharmaceuticals Announces Positive Data from MRI..
1/08/202418:44PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
12/12/202307:00PRNCAEupraxia Pharmaceuticals Announces Positive Clinical Data in..
12/11/202307:00PRNCAEupraxia Pharmaceuticals Announces Clinical and Corporate..
11/14/202317:01PRNCAEupraxia Pharmaceuticals Reports Third Quarter 2023..
11/01/202307:00PRNCAEupraxia Pharmaceuticals to Present at the 2023 Annual..
10/11/202307:00PRNCAEupraxia Pharmaceuticals Announces Initiation of Second..
9/11/202315:32PRNCAEupraxia Pharmaceuticals to Present at the H.C. Wainwright..
9/07/202317:00PRNCAEupraxia Pharmaceuticals Announces Change of Auditor
9/06/202317:00PRNCAEupraxia Pharmaceuticals Announces Presentation at PAINWeek..
8/18/202319:20PRNCAEupraxia Pharmaceuticals Announces Closing of Non-Brokered..
8/11/202317:00PRNCAEupraxia Pharmaceuticals Reports Second Quarter 2023..
8/04/202307:00PRNCAEupraxia Pharmaceuticals Announces a Non-Brokered Private..
6/26/202307:00PRNUSEupraxia Pharmaceuticals Reports Positive Topline Data in..
6/15/202318:42PRNCAEupraxia Pharmaceuticals Announces Filing of Preliminary..
6/13/202311:04DJNEupraxia Shares Climb After FDA Fast-Track Designation for..
6/13/202307:43DJNEupraxia Pharmaceuticals Gets FDA Fast-Track Designation for..
6/13/202307:00PRNCAEupraxia Pharmaceuticals Receives U.S. FDA Fast Track..
6/08/202307:00PRNCAEupraxia Pharmaceuticals Doses First Patient in Phase 1b/2a..
5/25/202307:00PRNCAEupraxia Pharmaceuticals Announces Last Patient Last Visit..
5/18/202307:00PRNCAEupraxia Pharmaceuticals Announces Appointment of Dr. Mark..
5/11/202307:00PRNCAEupraxia Pharmaceuticals Reports First Quarter 2023..

Your Recent History

Delayed Upgrade Clock